| Jul 2 |
Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
|
| Jul 2 |
Insiders At Regeneron Pharmaceuticals Sold US$26m In Stock, Alluding To Potential Weakness
|
| Jul 1 |
Regeneron (REGN) Gets Positive CHMP Opinion for Lymphoma Drug
|
| Jun 28 |
What's Going On With Regeneron Pharmaceuticals Stock On Friday?
|
| Jun 28 |
Regeneron lymphoma antibody drug endorsed for conditional approval in EU
|
| Jun 28 |
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
|
| Jun 27 |
Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
|
| Jun 27 |
3 Biotech Stocks That Could Make Your Grandchildren Rich
|
| Jun 26 |
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
|
| Jun 25 |
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Could Be 45% Below Their Intrinsic Value Estimate
|
